Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Eli Lilly and Company; Celgene; Puma Biotechnology, Inc.; Accelerate Brain Cancer Cure; Quadriga Biosciences, Inc.
  • المصدر:
    INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
    Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger AB. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 Jun 1;11(2):CNS87. doi: 10.2217/cns-2022-0005. Epub 2022 May 16.